Inhaled nitric oxide to treat intermediate risk pulmonary embolism: A multicenter randomized controlled trial.

[1]  S. Kahn,et al.  Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study. , 2017, The American journal of medicine.

[2]  J. Kline,et al.  Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism. , 2017, Thrombosis research.

[3]  J. Kline,et al.  Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial , 2017, American heart journal.

[4]  Fabian Bamberg,et al.  Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis. , 2015, The American journal of medicine.

[5]  J. Lafferty,et al.  Inhaled nitric oxide in acute pulmonary embolism: a systematic review. , 2015, Reviews in cardiovascular medicine.

[6]  S. Archer,et al.  Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension , 2015, Clinical pharmacology and therapeutics.

[7]  Jose Luis Zamorano,et al.  The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .

[8]  Jeroen J. Bax,et al.  ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[9]  M. Humbert,et al.  The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .

[10]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[11]  J. Kline,et al.  Severe pulmonary embolism decreases plasma l-arginine , 2013, European Respiratory Journal.

[12]  S. Middeldorp,et al.  Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. , 2013, Thrombosis research.

[13]  G. Hasenfuss,et al.  Predictive Value of the High-Sensitivity Troponin T Assay and the Simplified Pulmonary Embolism Severity Index in Hemodynamically Stable Patients With Acute Pulmonary Embolism: A Prospective Validation Study , 2011, Circulation.

[14]  J. Kline,et al.  Pulmonary vascular reserve during experimental pulmonary embolism: Effects of a soluble guanylate cyclase stimulator, BAY 41-8543* , 2011, Critical care medicine.

[15]  Sandeep K. Gupta,et al.  Intention-to-treat concept: A review , 2011, Perspectives in clinical research.

[16]  M. Eijkemans,et al.  No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism. , 2011, Thrombosis research.

[17]  M. Gladwin,et al.  Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. , 2011, JAMA.

[18]  M. Terry,et al.  Inhaled Nitrite Reverses Hemolysis-Induced Pulmonary Vasoconstriction in Newborn Lambs Without Blood Participation , 2011, Circulation.

[19]  S. Grifoni,et al.  Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. , 2010, Thrombosis research.

[20]  R. Yusen,et al.  Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. , 2009, Chest.

[21]  J. Kline,et al.  Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitation , 2009, Journal of thrombosis and haemostasis : JTH.

[22]  F. Klok,et al.  Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. , 2008, American journal of respiratory and critical care medicine.

[23]  L. Trinquart,et al.  Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. , 2008, European heart journal.

[24]  Jesse D. Roberts,et al.  Inhaled NO as a therapeutic agent. , 2007, Cardiovascular research.

[25]  J. Kline,et al.  Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. , 2006, Journal of molecular and cellular cardiology.

[26]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide A Selective Pulmonary Vasodilator Current Uses and Therapeutic Potential , 2004 .

[27]  E. Braunwald,et al.  Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion , 1993, The Lancet.

[28]  C. Elliott,et al.  Pulmonary physiology during pulmonary embolism. , 1992, Chest.

[29]  K. Mcintyre,et al.  Clinical and hemodynamic correlates in pulmonary embolism. , 1984, Clinics in chest medicine.

[30]  K. Mcintyre,et al.  Determinants of right ventricular function and hemodynamics after pulmonary embolism. , 1974, Chest.